Effect of three sewage isolated bacteriophages on the multidrug resistant pathogenic bacteria

Journal of Biological Sciences

Volumn 13, Issue 5, 2013, Pages 422-426

  Sadat Naghavi, Nafiseh ^a   Golgoljam, Mahdieh ^a   Akbari, Mojgan ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b UNIVERSITY OF ISFAHAN   (Iran)

Author keywords

Bacteria; Bacteriophage; Multidrug resistance; Pathogenic; Sewage

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; MACROLIDE; TETRACYCLINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOPHAGE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEWAGE; TRANSMISSION ELECTRON MICROSCOPY; VIRUS ISOLATION; VIRUS MORPHOLOGY;

EID: 84880070070     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2013.422.426     Document Type: Article

References (16)

1. Begum, Y.A., S. Chakraborty, A. Chowdhury, A.N. Ghosh, G.B. Nair et al., 2010. Isolation of a bacteriophage specific for CS7-expressing strains of enterotoxigenic Escherichia coli. J. Med. Microbiol., 59: 266-272.
2. Boule, J., P.L. Sholberg, S.M. Lehman, D.T. Ogorman and A.M. Svircev, 2011. Isolation and characterization of eight bacteriophages infecting Erwinia amylovora and their potential as biological control agents in British Columbia, Canada. Can. J. Plant Pathol., 33: 308-317.
3. Brooks, G.F., J.S. Butel and S.A. Morse, 2010. Jawets Melnick and Adelbergs Medical Microbiology. 24th Edn., McGraw Hill companies, USA.
4. Chan, B.K. and S.T. Abedon, 2012. Phage therapy pharmacology phage cocktails. Adv. Applied Microbiol, 78: 1-23.
5. Chhibber, S., S. Kaur and S. Kumari, 2008. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J. Med. Microbiol., 57: 1508-1513.
6. Foddai, A., C.T. Elliott and I.R. Grant 2009. Optimization of a phage amplification assay to permit accurate enumeration of viable Mycobacterium avium subsp. paratuberculosis cells. Applied Environ. Microbiol., 75: 3896-3902.
7. Garbe, J., B. Bunk, M. Rohde and M. Schobert, 2011. Sequencing and Characterization of Pseudomonas aeruginosa phage JG004. BMC Microbiol., Vol. 11. 10.1186/1471-2180-11-102
8. Hershey, A.D. and W. Dove, 1983. Introduction to Lambda. In: Lambda II, Hendrix, R.W., J.W. Roberts, F.W. Stahl and R.A. Weisberg (Eds.). Cold Spring Harbor Laboratory Press, USA., pp: 3-20.
9. Kmpe, D.M., P.M. Howley and D.E. Griffin, 2001. Fundamental Virology. 4th Edn., Lippincott Williams and Wilkins, Philadelphia, PA., USA.
10. Kochetkova, V.A., A.S. Mamontov, R.L. Moskovtseva, E.I. Erastova, E.I. Trofimov, M.I. Popov and S.K. Dzhubalieva, 1989. Phagorherapy of postoperative suppurative-inflammatory complications in patients with neoplasms. Sov. Med., 6: 23-26.
11. Mahon, M.R., D.C. Lehman and G. Manuselis, 2010. Textbook of Diagnostic Microbiology. 4th Edn., W.B. Saunders, USA.
12. Matsuzaki, S., M. Yasuda, H. Nishikawa, M. Kuroda and T. Ujihara et al., 2003. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MRU. J. Infect. Dis., 187: 613-624.
13. Meladze, G.D., M.G. Mebuke, N.S. Chkhetia, N.I. Kiknadze and G.G. Koguashvili et al., 1982. The efficacy of staphylococcal bacteriophage in treatment of purulent diseases of lungs and pleura. Grudn. Khir., 1: 53-56.
14. Sambrook, J., D.W. Russell, 2001. Molecular Cloning, A Laboratory Manual. 3rd Edn., Cold Spring Harbor Laboratory Press, USA.
15. Sulakvelidze, A., Z. Alavidze and J.G. Morris Jr., 2001. Bacteriophage therapy. Antimicrob. Agents Chemother., 45: 649-659.
16. Wills, Q.F., C. Kerrigan and J.S. Soothill, 2005. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob. Agents Chemother., 49: 1220-1221.